[
    [
        {
            "time": "2021-02-15",
            "original_text": "Italy's regulator approves conditional use of COVID-19 antibody therapies",
            "features": {
                "keywords": [
                    "regulator",
                    "approves",
                    "COVID-19",
                    "antibody",
                    "therapies"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Italy's regulator approves conditional use of COVID-19 antibody therapies",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 6,
                "Time_Proximity": 5,
                "Headline_Structure": 5,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-01-30",
            "original_text": "Pharma ETFs in Focus Post Q4 Earnings",
            "features": {
                "keywords": [
                    "Pharma",
                    "ETFs",
                    "Q4",
                    "Earnings"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Pharma ETFs in Focus Post Q4 Earnings",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-02-05",
            "original_text": "The Coming Alzheimer’s Crisis—and What to Do About It",
            "features": {
                "keywords": [
                    "Alzheimer’s",
                    "Crisis",
                    "Do",
                    "About"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "The Coming Alzheimer’s Crisis—and What to Do About It",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 4,
                "Duration": 7,
                "Entity_Density": 2,
                "Market_Scope": 5,
                "Time_Proximity": 4,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-02-10",
            "original_text": "An Aging Population Makes Alzheimer’s a More Pressing Concern—for Health Care and the Economy",
            "features": {
                "keywords": [
                    "Aging",
                    "Population",
                    "Alzheimer’s",
                    "Health",
                    "Care",
                    "Economy"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "economy"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "An Aging Population Makes Alzheimer’s a More Pressing Concern—for Health Care and the Economy",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 4,
                "Duration": 8,
                "Entity_Density": 2,
                "Market_Scope": 6,
                "Time_Proximity": 4,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-01-28",
            "original_text": "Pharma Stock Roundup: PFE, MRK Q4 Earnings, AZN, JNJ Coronavirus Vaccine Updates",
            "features": {
                "keywords": [
                    "Pharma",
                    "Stock",
                    "PFE",
                    "MRK",
                    "Q4",
                    "Earnings",
                    "AZN",
                    "JNJ",
                    "Coronavirus",
                    "Vaccine",
                    "Updates"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Pharma Stock Roundup: PFE, MRK Q4 Earnings, AZN, JNJ Coronavirus Vaccine Updates",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-02-12",
            "original_text": "FDA to issue guidance for vaccine developers about new variants",
            "features": {
                "keywords": [
                    "FDA",
                    "issue",
                    "guidance",
                    "vaccine",
                    "developers",
                    "variants"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "FDA to issue guidance for vaccine developers about new variants",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-02-18",
            "original_text": "Biogen Bet Big on Its Alzheimer’s Drug. The Stock Will Soar or Dive on the FDA’s Decision.",
            "features": {
                "keywords": [
                    "Biogen",
                    "Bet",
                    "Big",
                    "Alzheimer’s",
                    "Drug",
                    "Stock",
                    "Soar",
                    "Dive",
                    "FDA",
                    "Decision"
                ],
                "sentiment_score": 0.5,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "biotech",
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Biogen Bet Big on Its Alzheimer’s Drug. The Stock Will Soar or Dive on the FDA’s Decision.",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 10,
                "Impact": 10,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 10,
                "Source_Recency": 9
            }
        }
    ]
]